Literature DB >> 953366

Distribution of spermidine and spermine in blood from cystic fibrosis patients and control subjects.

L F Cohen, D W Lundgren, P M Farrell.   

Abstract

Previous studies have shown an abnormality of the spermidine-to-spermine (Spd/Spm) ratio in whole blood of cystic fibrosis homo-and heterozygotes. To investigate Spd and Spm distribution amoung blood components as a possible cause of the abnormality, blood was fractionated using Rabinowitz's glass bead technique and Boyum's Ficoll-Hypaque method. Free (unconjugated) polyamines were extracted with perchloric acid and quantitated on an amino acid analyzer. In controls, mean +/- SEM concentrations in nmoles/10(9) cells of Spd and Spm, respectively, were 1.02 +/- 0.08 and 0.894 +/- 0.28 for erythrocytes; 126 +/- 31 and 357 +/- 105 for lymphocytes; 36 +/- 16 and 240 +/- 33 for granulocytes; and less than 0.5 and less than 0.5 nmoles/ml for plasma. When converted to the concentration in whole blood, it was found that greater than 90% of Spd and over 70% of Spm was associated with erythrocytes. While the higher cellular concentration in leukocytes was not unexpected, the fact that Spd and Spm in whole blood were primarily associated with erythrocytes was a new finding. Comparison with controls revealed that the Spd/Spm ratio in both whole blood and erythrocytes was significantly higher in the group of cystic fibrosis patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 953366

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Inhibition and killing of fungi by the polyamine oxidase-polyamine system. Antifungal activity of the PAO-polyamine system.

Authors:  S M Levitz; D J DiBenedetto; R D Diamond
Journal:  Antonie Van Leeuwenhoek       Date:  1990-08       Impact factor: 2.271

2.  Inhibition of cation channels in human erythrocytes by spermine.

Authors:  Yuliya V Kucherenko; Florian Lang
Journal:  J Membr Biol       Date:  2010-11-10       Impact factor: 1.843

3.  Polyamines and neomycin inhibit the purified plasma-membrane Ca2+ pump by interacting with associated polyphosphoinositides.

Authors:  L Missiaen; F Wuytack; L Raeymaekers; H De Smedt; R Casteels
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

4.  Red blood cell polyamines as a diagnostic indicator of glioma presence and recurrence.

Authors:  P Elworthy; E Hitchcock
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

Review 5.  The mechanisms by which polyamines accelerate tumor spread.

Authors:  Kuniyasu Soda
Journal:  J Exp Clin Cancer Res       Date:  2011-10-11

6.  Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer.

Authors:  Naveena B Janakiram; Altaf Mohammed; Taylor Bryant; Yuting Zhang; Misty Brewer; Ashley Duff; Laura Biddick; Anil Singh; Stan Lightfoot; Vernon E Steele; Chinthalapally V Rao
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

7.  L-ornithine derived polyamines in cystic fibrosis airways.

Authors:  Hartmut Grasemann; Darakhshanda Shehnaz; Masahiro Enomoto; Michael Leadley; Jaques Belik; Felix Ratjen
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

8.  Raised polyamines in erythrocytes from melanoma-bearing mice and patients with solid tumours.

Authors:  H Takami; K Nishioka
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

9.  Food polyamine and cardiovascular disease--an epidemiological study.

Authors:  Kuniyasu Soda; Yoshihiko Kano; Fumihiro Chiba
Journal:  Glob J Health Sci       Date:  2012-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.